Rituximab Associated Necrosis: A Case Report

ConclusionThe present case raises the possibility of anti-CD20 antibody contributing to the development of palatal mucosal necrosis in some patients. Given the increasing administration of rituximab as a result of its efficacy against several diseases, a report on the potential iatrogenic effects of this drug is essential.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research